PLIANT THERAPEUTICS, INC. [FORM OF] DIRECTOR AND OFFICER INDEMNIFICATION AGREEMENTIndemnification Agreement • May 11th, 2020 • Pliant Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (“Agreement”) is made as of [________] by and between Pliant Therapeutics, Inc., a Delaware corporation (the “Company”), and [_____] (“Indemnitee”).
SUMMARY OF BASIC LEASE INFORMATIONLease • May 11th, 2020 • Pliant Therapeutics, Inc. • Pharmaceutical preparations • California
COLLABORATION AND LICENSE AGREEMENT BY AND BETWEENCollaboration and License Agreement • May 11th, 2020 • Pliant Therapeutics, Inc. • Pharmaceutical preparations • New York
This COLLABORATION AND LICENSE AGREEMENT (this "Agreement") is made as of October 17, 2019 (the "Execution Date"), by and between Novartis Institutes for Biomedical Research, Inc., a corporation organized and existing under the laws of the State of Delaware, located at 250 Massachusetts Avenue, Cambridge, Massachusetts 02139 ("NVS") and Pliant Therapeutics, Inc., a corporation organized and existing under the laws of the State of Delaware, located at 260 Littlefield Avenue, South San Francisco, CA 94080 ("Pliant"). NVS and Pliant are each referred to individually as a "Party" and together as the "Parties."
